Bets on financials, pharma power U.S. hedge funds' strong start to year
February 14, 2017 at 17:22 PM EST
NEW YORK, Feb 14 (Reuters) - Several big-name U.S. hedge fund investors in the fourth quarter moved significant parts of their portfolios into financial and pharmaceutical stocks that are expected to benefit under the Trump administration, helping to power the sector to its best January performance in four years.